Translating Psychedelic Experiences Into Targeted Health Outcomes: Optimism And Concern
Treating mental health disorders, such as addiction, depression, schizophrenia or post-traumatic stress disorder (PTSD), has not been as simple as swallowing a pill. The complexity of these disorders, and the […]
Demy-Colton Announces BioFuture™ Conference to be held at Cure, Deerfield’s Vertical Innovation Campus in New York City
NEW YORK–(BUSINESS WIRE)–Demy-Colton, a leader in connecting life science and digital health executives, announced today the launch of BioFuture, a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies […]
Biotech SPACs Can Expect a Good Runway as Investors Focus on Quality
Special Purpose Acquisition Companies (SPACs) are here to stay, offering one more way for companies to access public markets. But doing so isn’t a quick snap of the fingers. Companies […]
Sepsis: Standard of Care Fails While Novel Meds and Diagnostics Go Unused
Sepsis is among the best-known and least effectively treated conditions in the modern world. The standard of care has failed for these infections, leaving the U.S. healthcare system with $62 […]
Cervical cancer treatments bubbling in late-stage clinical efforts
The recent phase III win with Libtayo (cemiplimab-rwlc) in cervical cancer by Regeneron Pharmaceuticals Inc. and partner Sanofi SA turned more eyes to an indication hotly pursued in phase III […]
Determining Value is as Critical to Commercial Success as Clinical Data
The shifting focus from drug pricing to drug value is having a significant effect on innovation, performance and even investments. “Companies that don’t innovate on value will likely struggle to […]
AstraZeneca: ‘Manufacturing should take lion’s share of credit for vaccine success’
AstraZeneca says it has established more than 20 different supply nodes in parallel supply chains to roll out three billion doses of its COVID-19 vaccine this year. Late last month, […]
Cell and Gene Therapies Shatter Prior Records, with Continued Growth Expected
Cell and gene therapies achieved record growth in 2020, surpassing prior high points in terms of financings and approvals. Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM), painted a rosy […]
Until we meet again: Reflections from a JPMorgan Health Conference like no other
It was a year like no other for the healthcare industry, so why shouldn’t its premier investor meeting follow suit? When I first heard that the venerable JPMorgan Health Conference […]
Drug Prices Top of Mind as Pharma Leaders Consider Policies Under Biden
In many regards, the incoming Biden Administration is expected to be a redux of the Obama Administration, likely with strong support for scientific research and a reinvigoration of the Affordable […]